![The 47th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Sessions (O010 – O169) | Bone Marrow Transplantation The 47th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Sessions (O010 – O169) | Bone Marrow Transplantation](https://media.springernature.com/lw703/springer-static/image/art%3A10.1038%2Fs41409-021-01342-6/MediaObjects/41409_2021_1342_Figa_HTML.png)
The 47th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Sessions (O010 – O169) | Bone Marrow Transplantation
Novel Ultrasonographic Scoring System of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation
![Graft-Versus-Host Disease Prophylaxis Using Low-Dose Antithymocyte Globulin in Peripheral Blood Stem Cell Transplantation—A Matched-Pair Analysis - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation ... Graft-Versus-Host Disease Prophylaxis Using Low-Dose Antithymocyte Globulin in Peripheral Blood Stem Cell Transplantation—A Matched-Pair Analysis - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation ...](https://www.astctjournal.org/cms/attachment/a1a6c074-660f-4357-b080-19a90e221105/gr1_lrg.jpg)
Graft-Versus-Host Disease Prophylaxis Using Low-Dose Antithymocyte Globulin in Peripheral Blood Stem Cell Transplantation—A Matched-Pair Analysis - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation ...
![Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies | Request PDF Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies | Request PDF](https://i1.rgstatic.net/publication/366702994_Reduced_post-transplant_cyclophosphamide_doses_in_haploidentical_hematopoietic_cell_transplantation_for_elderly_patients_with_hematological_malignancies/links/63afb108097c7832ca7b2f4f/largepreview.png)
Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies | Request PDF
![PDF) HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning PDF) HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning](https://i1.rgstatic.net/publication/278787141_HLA-Haploidentical_Peripheral_Blood_Stem_Cell_Transplantation_with_Post-Transplant_Cyclophosphamide_after_Busulfan-Containing_Reduced-Intensity_Conditioning/links/5940959b45851554614aa4c4/largepreview.png)
PDF) HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning
![Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT | Blood Cancer Journal Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-022-00729-y/MediaObjects/41408_2022_729_Fig1_HTML.png)
Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT | Blood Cancer Journal
![The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Poster Session (P001-P706) | Bone Marrow Transplantation The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Poster Session (P001-P706) | Bone Marrow Transplantation](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41409-020-01120-w/MediaObjects/41409_2020_1120_Figa_HTML.png)
The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Poster Session (P001-P706) | Bone Marrow Transplantation
![EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment | Bone Marrow Transplantation EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41409-018-0204-7/MediaObjects/41409_2018_204_Fig1_HTML.png)
EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment | Bone Marrow Transplantation
![National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report - Transplantation and Cellular Therapy, Official Publication of the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report - Transplantation and Cellular Therapy, Official Publication of the](https://www.astctjournal.org/cms/attachment/30e65a53-ac5f-4934-8728-285682532547/gr1_lrg.jpg)
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report - Transplantation and Cellular Therapy, Official Publication of the
![PDF) Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia PDF) Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia](https://i1.rgstatic.net/publication/361206143_Post-transplant_cyclophosphamide_and_sirolimus_based_graft-versus-host_disease_prophylaxis_after_allogeneic_stem_cell_transplantation_for_acute_myeloid_leukemia/links/62a2b485416ec50bdb1ac521/largepreview.png)
PDF) Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia
![Prospective evaluation of alternative donor from unrelated donor and cord blood in adult acute leukemia and myelodysplastic syndrome | Request PDF Prospective evaluation of alternative donor from unrelated donor and cord blood in adult acute leukemia and myelodysplastic syndrome | Request PDF](https://i1.rgstatic.net/publication/339956988_Prospective_evaluation_of_alternative_donor_from_unrelated_donor_and_cord_blood_in_adult_acute_leukemia_and_myelodysplastic_syndrome/links/5fb396b4299bf10c36862bda/largepreview.png)
Prospective evaluation of alternative donor from unrelated donor and cord blood in adult acute leukemia and myelodysplastic syndrome | Request PDF
![Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report | Bone Marrow Transplantation Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbmt.2017.34/MediaObjects/41409_2017_Article_BFbmt201734_Fig1_HTML.jpg)
Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report | Bone Marrow Transplantation
![Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party | Bone Marrow Transplantation Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41409-021-01286-x/MediaObjects/41409_2021_1286_Fig1_HTML.png)
Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party | Bone Marrow Transplantation
![Antithymocyte Globulin Potentially Could Overcome an Adverse Effect of Acute Graft-versus-Host Disease in Matched-Related Peripheral Blood Stem Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society ... Antithymocyte Globulin Potentially Could Overcome an Adverse Effect of Acute Graft-versus-Host Disease in Matched-Related Peripheral Blood Stem Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society ...](https://www.astctjournal.org/cms/attachment/96aa3bcb-bed3-4f13-b444-dcff2aa0ed56/gr1_lrg.jpg)
Antithymocyte Globulin Potentially Could Overcome an Adverse Effect of Acute Graft-versus-Host Disease in Matched-Related Peripheral Blood Stem Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the American Society ...
Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups | Haematologica
![Assessment of the proposed EBMT pediatric criteria for diagnosis and severity grading of sinusoidal obstruction syndrome | Bone Marrow Transplantation Assessment of the proposed EBMT pediatric criteria for diagnosis and severity grading of sinusoidal obstruction syndrome | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41409-018-0426-8/MediaObjects/41409_2018_426_Fig1_HTML.png)
Assessment of the proposed EBMT pediatric criteria for diagnosis and severity grading of sinusoidal obstruction syndrome | Bone Marrow Transplantation
![GvHD Hub on Twitter: "#GvHDSummit Takanori Teshima, MD: Restoration of gut microbial ecology @TheEBMT #GvHD #gvhdsm #microbiota https://t.co/My6tHTP4bT" / Twitter GvHD Hub on Twitter: "#GvHDSummit Takanori Teshima, MD: Restoration of gut microbial ecology @TheEBMT #GvHD #gvhdsm #microbiota https://t.co/My6tHTP4bT" / Twitter](https://pbs.twimg.com/media/D6yEIIYXsAAneLu.jpg)
GvHD Hub on Twitter: "#GvHDSummit Takanori Teshima, MD: Restoration of gut microbial ecology @TheEBMT #GvHD #gvhdsm #microbiota https://t.co/My6tHTP4bT" / Twitter
![Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for Malignancy - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and ... Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for Malignancy - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and ...](https://www.astctjournal.org/cms/attachment/72374628-8a01-4d2e-b5de-ba3626704424/gr1_lrg.jpg)